Yes, you may be able to join the study if you:

• Are between 18 and 75 years of age

• Have type 2 diabetes for at least 6 months

• Have been taking an incretin therapy (either tirzepatide or semaglutide) at the same dose for at least 3 months

• Have a BMI of 27 or more